AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 59 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $104,381 | +5.4% | 7,692 | +33.2% | 0.00% | – |
Q2 2023 | $99,024 | +43.1% | 5,774 | +68.3% | 0.00% | – |
Q1 2023 | $69,203 | -27.0% | 3,431 | +6.1% | 0.00% | – |
Q4 2022 | $94,786 | +629.1% | 3,235 | +318.0% | 0.00% | – |
Q3 2022 | $13,000 | +116.7% | 774 | +87.0% | 0.00% | – |
Q2 2022 | $6,000 | -76.0% | 414 | -69.1% | 0.00% | – |
Q1 2022 | $25,000 | +127.3% | 1,341 | +42.5% | 0.00% | – |
Q4 2021 | $11,000 | -45.0% | 941 | 0.0% | 0.00% | – |
Q3 2021 | $20,000 | – | 941 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 603,762 | $8,193,050 | 18.42% |
TCG Crossover Management, LLC | 2,201,274 | $29,871,288 | 4.40% |
Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27,672,609 | 4.29% |
Sofinnova Investments, Inc. | 3,758,686 | $51,005,369 | 3.22% |
GREAT POINT PARTNERS LLC | 1,091,233 | $14,808,032 | 2.70% |
RA Capital Management | 8,263,982 | $112,142,236 | 2.21% |
Cormorant Asset Management, LP | 1,561,696 | $21,192,215 | 1.24% |
Frazier Life Sciences Management, L.P. | 1,204,867 | $16,350,045 | 1.09% |
Octagon Capital Advisors LP | 497,370 | $6,749,311 | 1.04% |
Ghost Tree Capital, LLC | 201,197 | $2,730,243 | 0.90% |